|
For the treatment of taxane-refractory tumors, and Satraplatin, a Phase 2 oral, anti-cancer drug, being investigated for non-small cell lung cancer (NSCLC).
More Info about Ortataxel
| Drug Type: | Cancer |
| Current FDA Status: | Unknown |
| Current Drug Phase: | Phase 2 |
|